Insider Transactions in Q4 2023 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2023
|
Samantha Prout Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,356
-19.16%
|
$326,984
$14.19 P/Share
|
|
Dec 28
2023
|
Jeff Castelli Chief Development Officer |
SELL
Open market or private sale
|
Direct |
17,421
-4.87%
|
$243,894
$14.52 P/Share
|
|
Dec 27
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.44%
|
$70,000
$14.07 P/Share
|
|
Dec 27
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+1.42%
|
$25,000
$5.16 P/Share
|
|
Dec 26
2023
|
Ellen Rosenberg Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
30,000
-8.06%
|
$420,000
$14.0 P/Share
|
|
Dec 26
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+7.46%
|
$150,000
$5.16 P/Share
|
|
Dec 26
2023
|
Samantha Prout Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,659
-5.91%
|
$107,226
$14.0 P/Share
|
|
Dec 20
2023
|
Jeff Castelli Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,654
-0.46%
|
$21,502
$13.1 P/Share
|
|
Dec 19
2023
|
Jeff Castelli Chief Development Officer |
SELL
Open market or private sale
|
Direct |
17,500
-4.64%
|
$227,500
$13.25 P/Share
|
|
Dec 18
2023
|
Jeff Castelli Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,643
+2.24%
|
-
|
|
Dec 18
2023
|
David Michael Clark Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,212
+3.19%
|
-
|
|
Dec 18
2023
|
John F Crowley Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
34,572
+3.65%
|
-
|
|
Dec 18
2023
|
Ellen Rosenberg Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,940
+2.82%
|
-
|
|
Dec 18
2023
|
Bradley L Campbell President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
17,286
+2.09%
|
-
|
|
Dec 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,043
-0.68%
|
$72,516
$12.66 P/Share
|
|
Dec 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,702
-1.46%
|
$128,722
$11.08 P/Share
|
|
Dec 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,702
+1.43%
|
$23,404
$2.94 P/Share
|
|
Dec 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,043
-0.68%
|
$66,473
$11.08 P/Share
|
|
Nov 15
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,043
-0.67%
|
$60,430
$10.84 P/Share
|
|
Nov 01
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.67%
|
$60,440
$10.97 P/Share
|
|
Nov 01
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,700
-1.46%
|
$117,000
$10.97 P/Share
|
|
Nov 01
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.43%
|
$23,400
$2.94 P/Share
|
|
Oct 16
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.67%
|
$60,440
$10.5 P/Share
|
|
Oct 02
2023
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
11,700
-0.73%
|
$128,700
$11.62 P/Share
|
|
Oct 02
2023
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,700
+1.43%
|
$23,400
$2.94 P/Share
|
|
Oct 02
2023
|
John F Crowley Executive Chairman |
SELL
Open market or private sale
|
Direct |
6,044
-0.33%
|
$66,484
$11.4 P/Share
|